Department of Pediatrics, Feinberg School of Medicine, Northwestern University and Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
Epilepsia. 2012 Sep;53(9):1481-8. doi: 10.1111/j.1528-1167.2012.03542.x. Epub 2012 Jun 14.
In a prospective study, Consequences of Prolonged Febrile Seizures in Childhood (FEBSTAT), we determined the frequency of human herpesvirus (HHV)-6 and HHV-7 infection as a cause of febrile status epilepticus (FSE).
Children ages 1 month to 5 years presenting with FSE were enrolled within 72 h and received a comprehensive assessment including specimens for HHV-6 and HHV-7. The presence of HHV-6A, HHV-6B, or HHV-7 DNA and RNA (amplified across a spliced junction) determined using quantitative polymerase chain reaction (qPCR) at baseline indicated viremia. Antibody titers to HHV-6 and HHV-7 were used in conjunction with the PCR results to distinguish primary infection from reactivated or prior infection.
Of 199 children evaluated, HHV-6 or HHV-7 status could be determined in 169 (84.9%). HHV-6B viremia at baseline was found in 54 children (32.0%), including 38 with primary infection and 16 with reactivated infection. No HHV-6A infections were identified. HHV-7 viremia at baseline was observed in 12 children (7.1%), including eight with primary infection and four with reactivated infection. Two subjects had HHV-6/HHV-7 primary coinfection at baseline. There were no differences in age, characteristics of illness or fever, seizure phenomenology or the proportion of acute EEG or imaging abnormalities in children presenting with FSE with or without HHV infection.
HHV-6B infection is commonly associated with FSE. HHV-7 infection is less frequently associated with FSE. Together, they account for one third of FSE, a condition associated with an increased risk of both hippocampal injury and subsequent temporal lobe epilepsy.
在一项前瞻性研究中,我们确定了人类疱疹病毒(HHV)-6 和 HHV-7 感染是否为热性惊厥持续状态(FSE)的病因。
年龄在 1 个月至 5 岁之间、出现 FSE 的儿童在发病后 72 小时内入组,并接受了全面评估,包括 HHV-6 和 HHV-7 的标本。使用聚合酶链反应(qPCR)在基线时定量检测 HHV-6A、HHV-6B 或 HHV-7 DNA 和 RNA(跨越拼接接头扩增),以确定是否存在病毒血症。HHV-6 和 HHV-7 的抗体滴度与 PCR 结果一起用于区分原发性感染、再激活感染或既往感染。
在 199 名接受评估的儿童中,有 169 名(84.9%)可以确定 HHV-6 或 HHV-7 的状态。在基线时发现 54 名儿童(32.0%)存在 HHV-6B 病毒血症,其中 38 名存在原发性感染,16 名存在再激活感染。未发现 HHV-6A 感染。在基线时发现 12 名儿童(7.1%)存在 HHV-7 病毒血症,其中 8 名存在原发性感染,4 名存在再激活感染。有 2 名儿童在基线时存在 HHV-6/7 原发性混合感染。与无 HHV 感染的儿童相比,出现 FSE 且有或无 HHV 感染的儿童在年龄、疾病特征或发热、惊厥表现或急性 EEG 或影像学异常的比例方面无差异。
HHV-6B 感染通常与 FSE 相关。HHV-7 感染与 FSE 的相关性较低。两者共同导致三分之一的 FSE,这种疾病与海马损伤和随后的颞叶癫痫的风险增加有关。